This spring has brought big-spending Yankees almost nothing but pain
Long-term injuries to Luis Gil and Gerrit Cole will immediately test New York's pitching depth, with Giancarlo Stanton ...
General Fusion's Made-in-Canada Technology Achieves First Plasma in Cutting Edge Fusion Demonstration Machine
“We’ve built 24 plasma injectors, created over 200,000 plasmas, and generated fusion neutrons from plasma compressions – de-risking LM26 and preparing us for this new chapter at General Fusion,” said ...
PyroGenesis and GE Vernova Sign Memorandum of Understanding (MOU)
PyroGenesis Inc. (“PyroGenesis”) ( (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes ...
Morningstar4d
General Fusion’s Made-in-Canada Technology Achieves First Plasma in Cutting Edge Fusion Demonstration Machine
2025 (GLOBE NEWSWIRE) -- General Fusion’s Magnetized Target Fusion (MTF) demonstration, Lawson Machine 26 (LM26), has successfully formed a magnetized plasma in the machine’s target chamber ...
The Manila Times1d
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...
The Print on MSN5d
This Bengaluru startup’s leading India’s nuclear fusion research—to light up a billion homes
Once mastered, nuclear fusion technology has the potential to change how humanity lives by providing a limitless, sustainable ...
MIT Technology Review1d
This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
The Manila Times4d
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with ...